Novak, Peter
Systrom, David M.
Marciano, Sadie P.
Knief, Alexandra
Felsenstein, Donna
Giannetti, Matthew P.
Hamilton, Matthew J.
Nicoloro-SantaBarbara, Jennifer
Saco, Tara V.
Castells, Mariana
Farhad, Khosro
Pilgrim, David M.
Mullally, William J.
Article History
Received: 8 August 2023
Accepted: 17 January 2024
First Online: 30 January 2024
Competing interests
: Dr. Novak is advisor/independent contractor for Dysimmune Diseases Foundation. He received royalties from Oxford University Press. Dr. Novak owns or owned stocks or stock options of Pfizer, Moderna, Editas Medicine and Novavax. The remaining authors have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper.